CB0306 has shown a good proof-of-concept in a relevant disease model of psychosis and cognition which has shown similarity to patterns observed in human disease conditions. The animal model exhibits hyperactivity, repeated circling behaviour and has sensorimotor gating deficit. These deficits are attenuated by CB0306. Our candidate has multi- functional potential for cognitive impairment in autism, schizophrenia and cognitive deficits.